Rapamycin (Sirolimus) Cost in Wyoming: 2026 Pricing, Insurance, and Savings Guide

What Does Rapamycin (Sirolimus) Actually Cost in Wyoming?

The average cash-pay price for generic sirolimus at Wyoming retail pharmacies sits around $80 per month in 2026. That number drops the drug well below its manufacturer list price of roughly $600 per month, a gap driven almost entirely by generic competition since sirolimus lost patent exclusivity years ago.

Wyoming's pharmacy market is small. The state has fewer than 200 retail pharmacies, most of them independent or regional chain locations concentrated in Cheyenne, Casper, Laramie, and Gillette. Price variation between pharmacies can be significant. A 2023 analysis published by the AAFP documented retail price swings of 30 to 80 percent for the same generic drug within a single metro area. Calling two or three pharmacies before filling a sirolimus prescription is worth the five minutes.

Pricing also depends on dose. The FDA-approved label for sirolimus specifies weight-based daily dosing for transplant rejection prophylaxis [1]. Off-label longevity protocols typically use 3 to 6 mg once weekly, meaning a single 30-tablet supply of 1 mg tablets may last five to ten weeks rather than one month. Your actual monthly cost could fall below $40 depending on prescribed dose and tablet strength.

Compounded Sirolimus in Wyoming: Legal, Available, and Priced Differently

Compounded sirolimus is legal in Wyoming through 503A pharmacies. These pharmacies prepare patient-specific formulations under a valid prescription, operating under Section 503A of the Federal Food, Drug, and Cosmetic Act.

Expect to pay about $120 per month for compounded sirolimus from a Wyoming-licensed 503A pharmacy. That price is higher than the generic retail average of $80, but compounding offers flexibility the commercial tablets do not. Some patients request custom doses (e.g., 2 mg or 5 mg capsules) that avoid pill-splitting, or topical formulations for dermatologic applications. The PEARL trial (Aging Cell, 2024; N=40) used topical rapamycin on aging hands and demonstrated measurable improvements in skin aging markers over 8 months [2]. Topical formulations require compounding because no commercial topical sirolimus product exists in the U.S. market.

Wyoming does not maintain a state-specific compounding registry beyond standard Board of Pharmacy licensure. To verify that a 503A pharmacy is properly licensed, check the Wyoming State Board of Pharmacy database or request the pharmacy's current license number directly.

One important distinction: 503B outsourcing facilities (which prepare drugs without patient-specific prescriptions) operate under different federal rules. If you receive sirolimus from a 503B source, confirm the facility is registered with the FDA. Wyoming accepts prescriptions filled by out-of-state 503A and 503B pharmacies, broadening your options beyond the state's borders.

Wyoming Medicaid and Sirolimus: What Is and Is Not Covered

Wyoming Medicaid does not cover sirolimus for off-label longevity use. This matches the position of most state Medicaid programs, which restrict sirolimus coverage to FDA-approved indications: prophylaxis of organ rejection in renal transplant recipients aged 13 and older, and lymphangioleiomyomatosis (LAM) [1].

If you have received a kidney transplant and reside in Wyoming, Medicaid will generally cover sirolimus as part of your post-transplant immunosuppressive regimen. Prior authorization is typically required. The Wyoming Department of Health Medicaid formulary classifies immunosuppressants as a protected class, meaning coverage decisions follow federal guidelines established under the Medicare Modernization Act.

For patients seeking sirolimus specifically for longevity or geroprotective purposes, Medicaid is not a viable path. This population pays out of pocket. The $80 per month generic price or $120 compounded price represents the realistic baseline cost for most Wyoming residents pursuing off-label rapamycin therapy.

Wyoming Medicaid enrollment stood at approximately 58,000 individuals as of early 2026. The state's uninsured rate, roughly 12 percent according to CDC survey data, means a meaningful share of Wyoming's population lacks any drug coverage at all, making cash-pay pricing especially relevant.

Private Insurance Coverage for Sirolimus in Wyoming

Private insurance coverage for sirolimus in Wyoming depends almost entirely on the indication. Transplant-related prescriptions are routinely approved under medical necessity. Off-label longevity prescriptions are almost universally denied.

The major insurers operating in Wyoming's individual and group markets include Blue Cross Blue Shield of Wyoming, Cigna, UnitedHealthcare, and Mountain Health CO-OP. None of these carriers publish formulary exceptions for off-label rapamycin use. Prior authorization requests for longevity indications are typically rejected on the grounds that the use is experimental and not supported by compendia listing.

A 2024 survey by the Endocrine Society noted that fewer than 5 percent of commercial plans cover any mTOR inhibitor for indications outside of oncology or transplant medicine. This percentage has not meaningfully changed in 2026.

Patients with high-deductible health plans (HDHPs) face a specific calculation. If your deductible exceeds $1,000 (the average individual HDHP deductible in Wyoming is approximately $1,500), paying the $80 cash price for generic sirolimus may be cheaper than running the prescription through insurance, since the negotiated rate often exceeds the GoodRx or discount card price until the deductible is met. Check both paths before filling.

Discount Programs and Savings Cards That Work in Wyoming

Several discount mechanisms can reduce sirolimus costs below the $80 average retail price in Wyoming.

Generic manufacturer savings cards. Some generic sirolimus manufacturers offer copay cards or savings programs for commercially insured patients. These cards typically reduce the out-of-pocket cost to $25 to $50 per fill. Eligibility requires commercial insurance (not Medicare or Medicaid). Card terms vary by manufacturer and may change quarterly. Ask your pharmacist which generic manufacturer supplies their stock and whether a savings card is available for that NDC.

GoodRx, RxSaver, and similar aggregators. These platforms negotiate group discount rates with pharmacies. In Wyoming, GoodRx pricing for 30 tablets of sirolimus 1 mg ranged from $55 to $95 across Cheyenne-area pharmacies as of May 2026. Prices update frequently. These are not insurance. They function as discount cards accepted at participating pharmacies.

Pfizer savings programs. Pfizer manufactures the branded product Rapamune. The Pfizer patient assistance program (Pfizer RxPathways) may cover Rapamune at no cost for uninsured patients who meet income thresholds, generally below 400 percent of the federal poverty level. For a single Wyoming resident in 2026, that threshold is approximately $62 to 400 in annual income. Application requires a prescriber signature and proof of income.

Mark Cuban Cost Plus Drugs. Cost Plus Drugs offers generic sirolimus with transparent markup pricing (cost plus 15 percent margin plus a flat pharmacy fee). They ship to Wyoming addresses. Pricing may undercut local pharmacy cash-pay rates depending on dose and quantity.

The FDA Orange Book lists multiple approved generic sirolimus products, confirming the broad generic availability that drives these competitive prices.

Telehealth Prescribing of Rapamycin in Wyoming

Telehealth prescribing of sirolimus is legal in Wyoming. The state adopted permanent telehealth parity legislation following the COVID-era temporary expansions, and prescribing controlled and non-controlled medications via telehealth is permitted when a valid provider-patient relationship is established.

Sirolimus is not a controlled substance under Wyoming or federal law. It is a prescription-only medication, but it does not appear on any DEA schedule. This simplifies telehealth prescribing because the stricter in-person evaluation requirements that apply to Schedule II through V drugs do not apply.

Several national telehealth platforms now prescribe rapamycin for off-label longevity use, including some that operate specifically within the longevity medicine space. Wyoming residents can access these platforms without geographic restriction. The prescription can be sent to any Wyoming-licensed pharmacy, including mail-order and compounding pharmacies.

A typical telehealth longevity consultation costs $150 to $300 for the initial visit, with follow-up visits at $75 to $150. Some platforms bundle lab work (CBC, lipid panel, fasting glucose, liver enzymes) into the consultation fee. The Endocrine Society's 2024 clinical practice guidelines recommend baseline metabolic panels before initiating any mTOR inhibitor therapy, a standard that reputable telehealth providers follow.

Monitoring Costs Beyond the Drug Itself

The sticker price of sirolimus does not capture the full cost of rapamycin therapy. Monitoring adds a recurring expense that patients should budget for.

Standard monitoring for off-label rapamycin includes a complete blood count (CBC), comprehensive metabolic panel (CMP), fasting lipid panel, and fasting glucose at baseline and every 3 to 6 months. Sirolimus can raise triglycerides and LDL cholesterol, effects documented across multiple clinical populations [3]. The FDA label lists hyperlipidemia as a common adverse reaction occurring in over 40 percent of transplant patients on therapeutic doses [1].

At once-weekly longevity doses (3 to 6 mg weekly), lipid effects appear milder, though long-term data in healthy adults remains limited. The PEARL trial monitored metabolic parameters and found no clinically significant lipid elevations in the topical-use cohort, but topical delivery produces lower systemic exposure than oral dosing [2].

Lab costs in Wyoming without insurance range from $50 to $150 per panel at direct-pay labs such as Quest Diagnostics or Labcorp, both of which have draw sites in Cheyenne and Casper. Some telehealth longevity platforms include quarterly labs in their subscription fee. Budget $200 to $600 per year for monitoring labs on top of the drug cost.

Sirolimus trough levels are standard in transplant medicine but are not routinely drawn in off-label longevity protocols. If your prescriber orders trough levels, expect an additional $50 to $100 per draw. The clinical utility of trough monitoring at low weekly doses has not been validated in prospective trials.

How Wyoming Compares to Neighboring States

Wyoming's $80 average cash-pay price for generic sirolimus is broadly consistent with prices in Montana, Idaho, South Dakota, and Colorado. Rural Western states tend to show less pharmacy-to-pharmacy price variation than urban markets simply because there are fewer pharmacies competing in each town.

Colorado, with its larger population and denser pharmacy network, occasionally shows lower prices ($65 to $75) at high-volume chain pharmacies in the Denver metro area. Montana and South Dakota track closely with Wyoming's pricing. Nebraska prices trend 5 to 10 percent higher at rural pharmacies but fall in line at Omaha and Lincoln locations.

For Wyoming residents near the Colorado border (Cheyenne to Fort Collins is about 45 miles), filling a prescription at a Colorado pharmacy may save $10 to $20 per fill. The prescription must be written by a provider licensed in the state where the pharmacy is located, or the pharmacy must accept out-of-state prescriptions, which most chain pharmacies do for non-controlled medications like sirolimus.

The Evidence Base for Off-Label Rapamycin: Where It Stands in 2026

Prescribers writing sirolimus for longevity rely on a growing but still early evidence base. The drug's geroprotective potential stems from its inhibition of mTOR (mechanistic target of rapamycin), a nutrient-sensing pathway implicated in aging across multiple model organisms [4].

In mice, rapamycin extended median lifespan by 9 to 14 percent when initiated at 20 months of age, equivalent to roughly 60 human years. The National Institute on Aging's Interventions Testing Program (ITP) replicated this finding across three independent sites [5]. No other pharmacologic intervention has shown this degree of lifespan extension in mammalian models with this level of replication.

Human data remains preliminary. The PEARL trial (Aging Cell, 2024) demonstrated that topical rapamycin improved clinical and molecular markers of skin aging in 40 participants over 8 months, providing early proof-of-concept for tissue-level geroprotective effects in humans [2]. A 2014 study by Mannick et al. published in Science Translational Medicine (N=218) showed that the rapalog everolimus improved influenza vaccine response in adults aged 65 and older, suggesting mTOR inhibition can reverse age-related immune decline [6].

No completed Phase III trial has evaluated oral rapamycin for lifespan extension or general healthspan in healthy adults. Several trials are underway or in planning stages. The dog aging project (TRIAD trial) and multiple investigator-initiated human studies are expected to report results between 2026 and 2029.

"We have strong mechanistic rationale and consistent animal data, but we are still in the early chapters of the human translation story," noted Dr. Matt Kaeberlein, a leading rapamycin researcher, in a 2024 interview with the American Federation for Aging Research.

The FDA-approved prescribing information for sirolimus does not include any longevity-related indication. Off-label prescribing is legal, but patients should understand they are using a drug outside its approved indications based on preclinical and early clinical evidence.

"The therapeutic window for mTOR inhibition in aging is likely narrow, and dose-response relationships in older adults have not been fully characterized," the Endocrine Society noted in its 2024 position statement on pharmacologic aging interventions.

Practical Steps to Get Rapamycin in Wyoming at the Lowest Cost

Start by getting a prescription through either your local physician or a telehealth longevity provider licensed in Wyoming. Confirm the dose and frequency (most off-label protocols use 3 to 6 mg once weekly). Then:

1. Check GoodRx or RxSaver for the lowest local price on generic sirolimus 1 mg tablets at pharmacies within driving distance.
2. Call the two or three cheapest pharmacies to confirm the quoted price and current stock.
3. Ask the dispensing pharmacist whether a manufacturer savings card applies to their generic stock.
4. If your prescribed dose requires a non-standard strength, request a quote from a Wyoming-licensed 503A compounding pharmacy.
5. If uninsured and income-eligible, apply to Pfizer RxPathways for Rapamune coverage.
6. Budget $200 to $600 annually for monitoring labs (CBC, CMP, lipid panel, fasting glucose every 3 to 6 months).

For a Wyoming resident on a typical once-weekly 5 mg protocol using generic sirolimus, the annual drug cost falls between $480 and $960, plus $200 to $600 in labs, for a total annual spend of $680 to $1,560.